Pancreatic Cancer Research

ResearcherUniversitätsklinikum Gießen und MarburgActive in the last 2 years

Jonathan M. Harnoss

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4272-5769; OpenAlex author ID A5043204412. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

  1. Tumor Location and Preoperative Biliary Stenting Shape Gut Microbiome Diversity in Pancreatic Cancer. Co-author DOI 10.3390/cancers18162617↗
  2. Preoperative biliary stenting is associated with functional dysbiosis and impaired bile acid metabolism in pancreatic cancer - Impact of preoperative biliary s… Co-author DOI 10.64898/2026.05.19.719953↗
  3. IRE1 is a promising therapeutic target in pancreatic cancer. Last author DOI 10.1152/ajpcell.00551.2024↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas P. Hank · 2 shared papers, 2026 · strength 0.47
  2. Ingmar Florin Rompen · 2 shared papers, 2026 · strength 0.47
  3. Marionna Cathomas · 2 shared papers, 2026 · strength 0.47
  4. Rogier Aäron Gaiser · 2 shared papers, 2026 · strength 0.47
  5. Franco Fortunato · 2 shared papers, 2026 · strength 0.47
  6. Max Heckler · 2 shared papers, 2026 · strength 0.47
  7. Christoph W. Michalski · 2 shared papers, 2026 · strength 0.47
  8. Bo Kong · 2 shared papers, 2026 · strength 0.47
  9. Peer Bork B · 2 shared papers, 2026 · strength 0.47
  10. Denise Lucas · 1 shared paper, 2025 · strength 0.28
  11. Martin Loos · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.